Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs01169971

Ligand	Ligand name	Chain	PDB	Tanimoto
MX3	(1-{4-[BENZYL(METHYL)AMINO]-4-OXOBUTANOYL}HYDRAZINO)ACETIC ACID	I	2C2O	0.72
F1K	(2S)-4-(4-fluorobenzyl)-N-(3-sulfanylpropyl)piperazine-2-carboxamide	A,B,C	2ZJK	0.73
GSB	S-BENZYL-GLUTATHIONE	A,B,C,D	1FRO	0.71
GSB	S-BENZYL-GLUTATHIONE	A,B,C,D	1GUH	0.71
PG1	PENICILLIN G ACYL-SERINE	A,B	1XA7	0.77
PG1	PENICILLIN G ACYL-SERINE	A	2IWC	0.77
PG1	PENICILLIN G ACYL-SERINE	A,B	1MWT	0.77
PNN	PENICILLIN G	A,B	1GM7	0.74
PNN	PENICILLIN G	B	1FXV	0.74
PNN	PENICILLIN G	A	1UOF	0.74
PNN	PENICILLIN G	A	1UOB	0.74
AIC	(2S,5R,6R)-6-{[(2R)-2-AMINO-2-PHENYLETHANOYL]AMINO}-3,3-DIMETHYL-7-OXO-4-THIA-1-AZABICYCLO[3.2.0]HEPTANE-2-CARBOXYLIC ACID	A	2RDD	0.76
AIC	(2S,5R,6R)-6-{[(2R)-2-AMINO-2-PHENYLETHANOYL]AMINO}-3,3-DIMETHYL-7-OXO-4-THIA-1-AZABICYCLO[3.2.0]HEPTANE-2-CARBOXYLIC ACID	A,B,C,D	1NX9	0.76
AIC	(2S,5R,6R)-6-{[(2R)-2-AMINO-2-PHENYLETHANOYL]AMINO}-3,3-DIMETHYL-7-OXO-4-THIA-1-AZABICYCLO[3.2.0]HEPTANE-2-CARBOXYLIC ACID	A	1H8S	0.76
AIC	(2S,5R,6R)-6-{[(2R)-2-AMINO-2-PHENYLETHANOYL]AMINO}-3,3-DIMETHYL-7-OXO-4-THIA-1-AZABICYCLO[3.2.0]HEPTANE-2-CARBOXYLIC ACID	A	2EX6	0.76
F1J	(2S)-4-(4-fluorobenzyl)-N-(2-sulfanylethyl)piperazine-2-carboxamide	A	2ZJJ	0.73
PNM	OPEN FORM - PENICILLIN G	A	1GHP	0.75
PNM	OPEN FORM - PENICILLIN G	A	1PWC	0.75
PNM	OPEN FORM - PENICILLIN G	A	1IYQ	0.75
PNM	OPEN FORM - PENICILLIN G	A	1FQG	0.75
PNM	OPEN FORM - PENICILLIN G	A,B,C,D	2J8Y	0.75
PNM	OPEN FORM - PENICILLIN G	A,B,C,D	2JBF	0.75
PNM	OPEN FORM - PENICILLIN G	A	2EX8	0.75
37U	D-phenylalanyl-N-(3-fluorobenzyl)-L-prolinamide	H,I	2ZDV	0.71
TR1	2-(2-{2-[(BIPHENYL-4-YLMETHYL)-AMINO]-3-MERCAPTO-PENTANOYLAMINO}-ACETYLAMINO)-3-METHYL-BUTYRIC ACID METHYL ESTER	A,B	1C8T	0.76
TR1	2-(2-{2-[(BIPHENYL-4-YLMETHYL)-AMINO]-3-MERCAPTO-PENTANOYLAMINO}-ACETYLAMINO)-3-METHYL-BUTYRIC ACID METHYL ESTER	A,B	1C3I	0.76
BM5	(R)-(+) 5(9BH)-OXO-9B-PHENYL-2,3-DIHYDROTHIAZOLO[2,3-A]ISOINDOL-3-CARBOXYLIC ACID METHYL ESTER	A	1C0U	0.74
T29	TRI166 (BIFUNCTIONAL BORONATE INHIBITOR)	H	1A3B	0.7
C28	N-[1-(AMINOMETHYL)CYCLOPROPYL]-3-(MORPHOLIN-4-YLSULFONYL)-N~2~-[(1S)-2,2,2-TRIFLUORO-1-(4-FLUOROPHENYL)ETHYL]-L-ALANINAMIDE	A,B	2FT2	0.7
SOX	N-[(2S,4S,6R)-2-(DIHYDROXYMETHYL)-4-HYDROXY-3,3-DIMETHYL-7-OXO-4LAMBDA~4~-THIA-1-AZABICYCLO[3.2.0]HEPT-6-YL]-2-PHENYLACETAMIDE	B	1GM8	0.73
SOX	N-[(2S,4S,6R)-2-(DIHYDROXYMETHYL)-4-HYDROXY-3,3-DIMETHYL-7-OXO-4LAMBDA~4~-THIA-1-AZABICYCLO[3.2.0]HEPT-6-YL]-2-PHENYLACETAMIDE	A,B	1GM9	0.73
DOE	(S)-2-(4-(2-(2-HYDROXYETHYLTHIO)-ACETAMIDO)-BENZYL)-1,4,7,10-TETRAAZACYCLODODECANE-N,N',N'',N'''-TETRAACETATE	A,B,C,D	1NC2	0.71
PN1	(2S,6R)-6-{[(2R)-2-AMINO-2-PHENYLETHANOYL]AMINO}-3,3-DIMETHYL-7-OXO-4-THIA-1-AZABICYCLO[3.2.0]HEPTANE-2-CARBOXYLIC ACID	A	1W2N	0.76
PN1	(2S,6R)-6-{[(2R)-2-AMINO-2-PHENYLETHANOYL]AMINO}-3,3-DIMETHYL-7-OXO-4-THIA-1-AZABICYCLO[3.2.0]HEPTANE-2-CARBOXYLIC ACID	A	1UNB	0.76
G23	(2R,4S)-2-[(R)-BENZYLCARBAMOYL-PHENYLACETYL-METHYL]-5,5-DIMETHYL-THIAZOLIDINE-4-CARBOXYLIC ACID	A	1HTE	0.77
CRJ	N-(1-CYANOCYCLOPROPYL)-3-({[(2S)-5-OXOPYRROLIDIN-2-YL]METHYL}SULFONYL)-N~2~-[(1S)-2,2,2-TRIFLUORO-1-(4-FLUOROPHENYL)ETHYL]-L-ALANINAMIDE	A,B	2FQ9	0.71
TI1	[2(R,S)-2-SULFANYLHEPTANOYL]-PHE-ALA	A	1R1I	0.71
TI1	[2(R,S)-2-SULFANYLHEPTANOYL]-PHE-ALA	A	1QF1	0.71